CEO Eric Dube (Travere Therapeutics)
Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics
Retrophin is shedding the last of its ties to convicted “Pharma Bro” Martin Shkreli and his failed neurological drug — with a name change.
“That name …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
